A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.
about
Fish oil: what the prescriber needs to knowNon-immunosuppressive treatment for IgA nephropathyOmega 3 fatty acids for prevention and treatment of cardiovascular diseaseThe role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis)Race/ethnicity and disease severity in IgA nephropathyA randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]Recent advances in the understanding and management of IgA nephropathyLong-chain polyunsaturated fatty acid sources and evaluation of their nutritional and functional propertiesThe effects of dietary lipids on gene expression and apoptosis.The ω-3 polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodeling.Refractory Cutaneous IgA Vasculitis Treated with Omega-3 Fatty Acids.Omega-3 and renal function in older adults.Rationales for treating IgA nephropathies.Signaling pathways modulated by fish oil in salt-sensitive hypertensionn-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis.Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysisEffect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial.Complementary and alternative medicine: assessing the evidence for immunological benefits.Addition of DHA Synergistically Enhances the Efficacy of Regorafenib for Kidney Cancer Therapy.Military nephrology: magnitude of rates of deterioration in renal function.Asymptomatic microscopic or dipstick haematuria in adults: which investigations for which patients? A review of the evidence.n-3 Fatty acids block TNF-α-stimulated MCP-1 expression in rat mesangial cells.Inhibition of leukocyte-endothelial interactions by oxidized omega-3 fatty acids: a novel mechanism for the anti-inflammatory effects of omega-3 fatty acids in fish oil.Nutrition and dietary intake and their association with mortality and hospitalisation in adults with chronic kidney disease treated with haemodialysis: protocol for DIET-HD, a prospective multinational cohort study.Association between serum long-chain n-3 and n-6 polyunsaturated fatty acid profiles and glomerular filtration rate assessed by serum creatinine and cystatin C levels in Japanese community-dwellers.Evidence-based guide to slowing the progression of early renal insufficiency.Outcome results in children with IgA nephropathy: a single center experienceTherapeutic approach of patients with IgA nephropathy.Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients.Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia.Diagnosis and treatment of nephrotic syndrome.The effects of n-3 fatty acids on inflammatory cytokines in osteoporotic spinal cord injured patients: A randomized clinical trialIgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.Seafood consumption and components for health.Leukocyte numbers and function in subjects eating n-3 enriched foods: selective depression of natural killer cell levelsSerum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations.Plasma polyunsaturated fatty acids and the decline of renal function.Enhanced absorption of n-3 fatty acids from emulsified compared with encapsulated fish oilMechanisms for suppression of interleukin-6 expression in peritoneal macrophages from docosahexaenoic acid-fed miceSuppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV
P2860
Q21195667-2A02C21E-7CE2-432B-A579-3A67956420C4Q24235956-DD8FB6E7-80FD-48C9-8CF1-6D292C28C1EDQ24245810-5B9A0033-AD6C-4F14-85B7-5D2FA3DD5F78Q24649593-EC17456B-9692-468E-AF91-8B8A736562D4Q24791691-546EBF76-958D-4C2B-B4DC-F9430CFEE716Q24800133-358863ED-F8A4-4991-9502-8831500B64E3Q26766126-70C8633E-980B-42B7-AE46-8E5691BF453AQ27028080-B0E43D7A-3A06-44B0-8E92-7388EEC420F1Q33545949-4579042F-0A55-4162-954F-72B6C34B9974Q33567788-EAAAA9BC-30F5-422F-B7F9-574778BA3C6AQ33574681-FBF3832D-9D4E-444B-8C9E-9111610BF12EQ33825369-B3406F52-908E-4AE5-9B67-B346A7051056Q33863555-7F49FD0E-DFB0-4A97-81FE-FEDC3887803DQ33887250-8FDC5DA3-EEBD-44EA-BD1E-DE5C95918FF3Q33911052-20E327CF-82B4-4142-B019-F2D46EE16E66Q33919210-294F62DA-6F59-4C95-894B-B32802654357Q34292912-03C4BEA1-2464-4246-A965-265E03CD8519Q34363569-FCACF47E-0BEF-4DF4-A0F1-49A2FF6EB2EDQ34515993-0C725D7E-D1F3-45DC-B726-D1E30CFA5296Q34747330-A56409F7-B059-4D30-849A-C9373C4E5728Q34754190-E59020F9-CD69-493E-871F-C8BD77F77969Q34979637-ADB9918B-EBB2-4BA4-9992-C526A9815517Q35081219-5A4565DE-6775-42F8-AB75-96E3007DBC27Q35203792-2B4F13C5-EE54-40B2-AB23-525FFB69C833Q35221021-A4FEEEE3-39B8-4C33-8C89-4A5D6579424EQ35641499-C064C443-CB76-460E-A49B-CEEB184FD7A6Q35753153-C62DC611-1268-4C0C-9897-0BB63B9ED036Q35852475-B6A25C88-1EC8-4BF9-B597-C70F4F37D2D8Q35995685-17157207-4FED-4AF2-B78E-F0C64C8D06ECQ36005146-8F4176BC-F780-4043-81C5-0CB27109AF6CQ36181350-96E93959-DE2B-42F6-8E72-7D79885988E4Q36477533-1282275E-C9AD-4738-9A9E-1E69DDE0EB09Q36577108-97BEDC64-B6BD-47E2-9EF1-3F346DAF1404Q36648133-65502D80-4089-4240-823B-63EF53206CE1Q36790361-E2CE8428-2DAF-42EA-B90D-AC3E268D8D88Q36979196-DE426C6E-E5B1-44DD-B0A8-BFFBEA0AE0F4Q37104534-BD836045-0DA2-4549-96C2-23BA97AAB758Q37240742-3B359D8E-31CE-4370-AC77-33F8F01953D6Q37305715-9C53C85E-57EF-4A8C-A8AA-09B76B2E4CAFQ37357316-CCBE352D-6128-4165-BC5A-1105821D0035
P2860
A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.
description
1994 nî lūn-bûn
@nan
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.
@ast
A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.
@en
A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.
@nl
type
label
A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.
@ast
A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.
@en
A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.
@nl
prefLabel
A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.
@ast
A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.
@en
A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.
@nl
P2093
P1476
A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.
@en
P2093
Bergstralh EJ
Donadio JV Jr
Spencer DC
P304
P356
10.1056/NEJM199411033311804
P407
P577
1994-11-01T00:00:00Z